PR Newswire

The newsfeed available here is provided by our content partner PR Newswire. This is one of the most important and widest-reaching press services, providing news, press releases and multimedia content to the media, journalists and the public.
The NewsWire Hub ("X-Billboard") currently comprises four of the most important international news sources and is supplemented by a stock market information service. The individual newswire services complement each other and provide a complementary range of information, more than three quarters of the official news sources on which editors worldwide base their stock market reporting. Your advantage: You will find everything here in one overview. You can navigate to the individual sections using the control elements. In the terminal view, you can carry out individual searches at company level.
presented by
N
More Tools & Gadgets
System-State: Number of processed items 50.081 Notifications successully processed since Inception
PR Newswire is an important news source that can be accessed via the X-Billboard. It is part of the Newswire Hub, which bundles important international news sources for stock market participants in one central location. If you want to get a quick overview, you can easily scroll through the headlines. If you want to look at the news in more detail, you can use the detailed views of the info cards to directly access the respective news item and other analysis tools.
NEWS
EXPLORER
US00846U1016
State: 17.08.2024 | 11PM
Do you already know our new terminal view? Click here.
FIGI: BBG000C2V3D6
A
Agilent Technologies, Inc.
GICS: 35203010 · Sector: Healthcare · Sub-Sector: Medical - Diagnostics & Research
NAME
Agilent Technologies, Inc.
ISIN
US00846U1016
TICKER
A
MIC
XNYS
REUTERS
A.N
BLOOMBERG
A US
Fri, 04.10.2024       Agilent Technologies
US00846U1016

Center will enable targeted and untargeted metabolic profiling for population-based large-scale cohorts across translational research

SINGAPORE, Oct. 4, 2024 /PRNewswire/ -- Agilent Technologies Inc. (NYSE: A) today announced a new strategic partnership with National University of Singapore (NUS), acting through the Yong Loo Lin School of Medicine (NUS Medicine), to establish the NUS-Agilent Center of Excellence (CoE) in Cell Metabolism, a scientific collaboration to advance cardiovascular and metabolic disease translational research over the next four years.   

Read More
Agilent Technologies
Technical Analysis Termsheet Terminal
Permalink
Mon, 22.07.2024       Agilent Technologies
US00846U1016

SINGAPORE, July 22, 2024 /PRNewswire/ -- Agilent Technologies Inc. (NYSE: A) today announced the release of its new ProteoAnalyzer system, in addition to existing product updates at the Singapore Cell and Gene Therapy Pan Asia Summit (SCGT). 

Agilent's new protein analysis platform, an automated parallel capillary electrophoresis (CE) solution, combines rapid, high-resolution analysis with minimal sample consumption. This allows researchers to examine complex protein mixtures, enabling faster discoveries in pharma, biopharma, and bioengineered food ingredients. 

Read More
Agilent Technologies
Technical Analysis Termsheet Terminal
Permalink
Thu, 23.05.2024       Agilent Technologies
US00846U1016

New instrument delivers the full power and capability of Agilent GCs in a compact design

SANTA CLARA, Calif., May 23, 2024 /PRNewswire/ -- Agilent Technologies Inc. (NYSE: A) proudly announces the 8850 Gas Chromatograph (GC) System, a small single-channel GC that combines the legacy of the 6850 GC with the capability and system intelligence of the 8890 GC. With a focus on speed and intelligence, the 8850 GC stands poised to revolutionize labs across diverse markets, including energy, chemicals, food, and pharmaceuticals while reducing energy consumption up to 30%.

Read More
Agilent Technologies
Technical Analysis Termsheet Terminal
Permalink

The information provided here is not subject to any editorial processing. It is prepared fully automatically and enriched with additional information and further research options. The aim of the content is to provide information seekers with the relevant information quickly and easily. A link back to the information provider and owner ensures that the data prepared here can be compared with the source information if required. The newsboard does not show information in real time. Please contact the exchange operator for this information if required. There is no claim to completeness. High availability cannot be guaranteed. If you notice any errors in the functionality, please let us know using the "Report a Bug" form below.

RAW DATA PROCESSING means that raw data is processed without changing the content. The data is supplemented to improve the interpretation of the information in terms of usability.

Note: The newswire cross-link panel at the top allows you to quickly and easily access additional sources of information. In the terminal view, the news is filtered at company level and enables targeted searches.

On behalf of the trading community, we would like to thank the operators of the trading venues for providing information services.